DDD.’aRcy Duquette

D.’aRcy Duquette

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


D.’aRcy Duquette has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Midodrine for the early liberation from vasopressor support in the ICU (LIBERATE): A Vanguard Randomized Clinical Trial

    by Dawn Opgenorth, Fadi Hammal, Deborah J. Cook, D’arcy Duquette, Stephanie Sibley, Jennifer Tsang, Janek Senaratne, Kirsten Fiest, Vincent Lau, Fernando G Zampieri, et al.

    Background: Intravenous (IV) vasopressors are the mainstay of hemodynamic physiological support for critically ill patients. However, the role of oral vasopressors in the management of IV vasopressor-dependent shock remains unclear. The LIBERATE body of work aims to examine the role of midodrine as an IV vasopressor sparing agent for critically ill patients with IV vasopressor dependent shock. The objective of the LIBERATE Vanguard Study was to evaluate the implementation of the LIBERATE protocol in a multi-centre randomized control trial setting. Methods: We conducted a pilot multi-centre, concealed-allocation, parallel-group, blinded randomized controlled trial (RCT) evaluating the effect of oral midodrine versus placebo on the duration of IV vasopressor-dependent shock in the intensive care unit (ICU) on the first 20% of planned sample size for the LIBERATE trial. The study was performed in 9 Alberta and Ontario medical centres between September 16, 2022 and September 30, 2024. We included patients aged 18 years or older admitted to the ICU receiving ongoing IV vasopressor support. Patients were randomly assigned 1:1 to enteral midodrine or an identical placebo and received the study treatment until 24 hours after discontinuation of their IV vasopressor therapy. The primary endpoints were study feasibility and included: recruitment rate (monthly enrollment per study site), screening and enrollment characteristics, protocol adherence, retention rate, data completeness, and safety (adverse event reporting), Secondary endpoints focused on aggregate patient-centered outcomes. Results: 174 patients fulfilled eligibility criteria and were enrolled in the trial. The mean age was 61.5 (SD 15.3) and 68 (40.2%) were female. The mean Acute Physiology and Health Evaluation (APACHEII) score at ICU admission was 23.5 (SD 7.3) and the mean Sequential Organ Failure Assessment (SOFA) score at time of study enrollment was 10.2 (SD 2.9). Sepsis was the most common cause of shock in both groups. Average recruitment was 1.6 participants (range 0.4 to 3.0) per study site per month, protocol adherence was 83.9%, retention rate was 97.1%, and there were no reports of unblinding of treatment allocation by the study sites. 2 adverse events were reported and resolved with no sequelae. Conclusion: The LIBERATE Vanguard trial is feasible and safe, supporting a larger trial to investigate the utility of midodrine in critically ill patients with IV vasopressor dependent shock. Trial Registration: Registered September 28, 2021. https://clinicaltrials.gov/study/NCT05058612

  • Open Access

    “I think there has to be a mutual respect for there to be value”: Evaluating patient engagement in a national clinical trial on de-implementation of low value care

    by Holly Etchegary, Stefanie Linklater, D.’aRcy Duquette, Gloria Wilkinson, Vanessa Francis, Erin Gionet, Andrea M. Patey, Jeremy M. Grimshaw

    Background: The evaluation of patient engagement in research is understudied and under-reported, making it difficult to know what engagement strategies work best and when. We provide the results of an evaluation of patient engagement in a large Canadian research program focused on the de-implementation of low-value care. We aimed to evaluate the experience and impact of patient engagement in the study. Methods: An online cross-sectional survey was administered using Microsoft Forms to (1) researchers and study staff and (2) patient partners. The survey was developed following iterative reviews by the project’s patient partnership council and evaluation committee. Survey content areas included opinions on patient engagement to date, including challenges to engagement and suggestions for improvement. Patient partners also evaluated the partnership council. Descriptive statistics including counts and percentages described Likert scale survey items, while open comments were analyzed using descriptive content analysis. Results: The survey response rate was 46% (17/37). There were positive attitudes about the value of patient engagement in this project. There was also a high degree of willingness to be involved with patient engagement in future projects, whether as a patient partner or as a researcher including patients on the research team. Most patient partners felt their contributions to the project were valued by researchers and study research staff. Open comments revealed that a co-design approach and full inclusion on the research team were integral to demonstrating the value of patient partner input. Areas for improvement included more frequent and ongoing communication among all team members, as well as earlier training about patient engagement, particularly addressing role expectations and role clarity. Conclusions: Our data revealed that despite some challenges, team members recognized the value of patient engagement in research and agreed project decisions had been impacted by patient partner input. Ongoing communication was highlighted as an area for improvement, as well as earlier training and ongoing support for all team members, but particularly researchers and study staff. In response to evaluation data, the team has reinstated a quarterly newsletter and plans to use specific patient engagement planning templates across study sites for all project activities. These tools should help make expectations clear for all team members and contribute to a positive patient engagement experience. Findings can inform patient engagement planning and evaluation for other health research projects.